KROS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

KROSKeros Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

KROSKeros Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

KROSKeros Therapeutics, Inc.

11.14▲+2.88%

Mkt cap$214.7MRevenue$367,000Q1 FY26Revenue$244MFY25

LLYELI Lilly & Co

1,418.02▲+0.61%

Regular sessionNov 4 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 4 '26

KROSKeros Therapeutics, Inc.

LLYELI Lilly & Co

11.14▲+2.88%

Price

1,418.02▲+0.61%

$214.7M

Mkt cap

$1.3T

Q1 FY26$367,000

Revenue

$24.4BQ3 FY26

FY25$244M

Revenue

$65.2BFY25

KROS11.14▲+2.88%vsLLY1,418.02▲+0.61%Regular sessionNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

KROS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KROS 4

TAKTakeda Pharmaceuticalcustomer

—The General Hospitalunlistedsupplier

—Hansoh (Shanghai) Healthtechunlistedcustomer

—Takeda Pharmaceuticals U.S.Aunlistedcustomer

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

KROS, solidLLY, dashed